Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
N. Paran, Y. Yahalom-Ronen, O. Shifman, S. Lazar, R. Ben-Ami, M. Yakubovsky, I. Levy, A. Wieder Feinsod, S. Amit, M. Katzir, N. Carmi Oren, A. Levcovich, M. Hershman-Sarafov, A. Paz, R. Thomas, , T. Israely
The paper correlates Monkeypox DNA content with virus infectivity in clinical samples and defines a PCR threshold for non-infectious virus.
bioRxiv · Aug 2, 2022 · PreprintMicrobiology
S. Melamed, B. Politi, E. Grauer, H. Achdout, M. Aftalion, D. Gur, H. Tamir, Y. Yahalom-Ronen, S. Maimon, E. Yitzhak, S. Weiss, A. Rosner, N. Erez, S. Yitzhaki, S. C. Shapira, , T. Israely
This study uses group activity monitoring in hamsters and mice to assess SARS-CoV-2 infection, convalescence, and vaccine efficacy.
Frontiers in Bioengineering and Biotechnology · Oct 1, 2021Peer-reviewedImmunology
N. Madar-Balakirski, A. Rosner, S. Melamed, B. Politi, M. Steiner, H. Tamir, Y. Yahalom Ronen, E. Bar-David, A. Ben-Shmuel, A. Sittner, I. Glinert, S. Weiss, E. Bar-Haim, H. Cohen, U. Elia, , H. Marcus
This study evaluates the safety, immunogenicity, and efficacy of an rVSV-ΔG-SARS-CoV-2-S vaccine in multiple animal species, finding no adverse effects and a robust immune response.
bioRxiv · Jul 6, 2021Pharmacology & Toxicology
A. E. Chaouat, H. Achdout, I. Kol, O. Berhani, G. Roi, E. B. Vitner, S. Melamed, B. Politi, E. Zahavi, I. Brizic, T. Lenac Rovis, O. B. Alfi, D. Wolf, S. Jonjic, T. Israely, O. Mandelboim
This paper develops RBD-Ig fusion proteins that efficiently neutralize SARS-CoV-2 infection in vitro and in vivo, outperforming ACE2-Ig.
bioRxiv · Apr 18, 2021Immunology
R. Falach, L. Bar-On, S. Lazar, T. Kadar, O. Mazor, M. Aftalion, D. Gur, O. Shifman, O. Israeli, I. Cohen-Gihon, G. Zaide, H. Gutman, Y. Evgy, Y. Vagima, E. Makdasi, , T. Sabo
This study shows that CD-1 mice with induced pulmonary comorbidities develop severe lung inflammation and high mortality after SARS-CoV-2 infection.
bioRxiv · Oct 28, 2020 · PreprintPathology
R. Rosenfeld, T. Noy-Porat, A. Mechaly, E. Makdasi, Y. Levy, R. Alcalay, R. Falach, M. Aftalion, E. Epstein, D. Gur, T. Chitlaru, E. B. Vitner, S. Melamed, B. Politi, A. Zauberman, , O. Mazor
This study shows that the human monoclonal antibody MD65 can rescue 100% of SARS-CoV-2 infected mice when administered up to 3 days post-exposure.
bioRxiv · Oct 26, 2020Immunology
Y. Yahalom-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E. Milrot, D. Stein, I. Cohen-Gihon, S. Lazar, H. Gutman, I. Glinert, L. Cherry, , T. Israely
This study develops a recombinant VSV-ΔG-spike vaccine that provides single-dose protection against SARS-CoV-2 in hamsters by inducing neutralizing antibodies and preventing lung pathology.
bioRxiv · Jun 18, 2020Microbiology
E. B. Vitner, R. Avraham, H. Achdout, H. Tamir, A. Agami, L. Cherry, Y. Yahalom-Ronen, B. Politi, N. Erez, S. Melamed, N. Paran, T. Israely
The study evaluates two GCS inhibitors for antiviral activity against four enveloped RNA viruses, including SARS-CoV-2, showing broad-spectrum efficacy and improved survival in infected mice.
bioRxiv · May 18, 2020 · PreprintMicrobiology